Friday, May 17

Family Considers Lawsuit Against Serum Institute of India Over Alleged Covishield-Related Death

Edited by Aishwarya Krishnan

The family of a woman who reportedly died after receiving the Covishield vaccine is contemplating legal action against the Serum Institute of India (SII). This decision follows recent revelations by British pharmaceutical company AstraZeneca regarding potential rare side effects associated with its vaccine.

Karunya, the daughter of Venugopalan Govindan, tragically passed away in July 2021 after receiving the Covishield vaccine. A national committee established by the government concluded that there was insufficient evidence to directly link her death to the vaccine.

Developed collaboratively by AstraZeneca and Oxford University, the AstraZeneca-Oxford vaccine was sold across the globe under brand names including ‘Covishield’ and ‘Vaxzevria.’ The vaccine was produced by the Serum Institute.

Previously, some parents petitioning the court attributed their children’s deaths to the vaccine’s administration. However, the petition targeted the government and the bodies responsible for authorising the vaccine, with the Serum Institute not directly involved in those cases.

According to the parents of Rithaika Sri Omtri, who passed away in June 2021 at the age of 18, she died due to acute Cerebral Venous Sinus Thrombosis (CVST) triggered by Vaccine-Induced Thrombotic Thrombocytopenia (VITT).

Recently, AstraZeneca admitted in a UK court, as part of an ongoing class-action lawsuit, the potential rare side effect of blood clotting coupling with the low platelet count associated with its vaccine. This revelation has created a massive row, leading to the AstraZeneca-Oxford vaccine being discontinued in the UK due to safety concerns.

Following the death of Jamie Scott (44) who experienced vomiting leading to a speech impairment after receiving vaccination in April 2021, over 50 cases were registered against the pharma giant. Scott was diagnosed with a suspected case of VITT.